Lista de obras - Masashi Narazaki - Dominio Público Uruguay

A case of Behçet's disease treated with a humanized anti-interleukin-6 receptor antibody, tocilizumab.

artículo científico publicado en 2011

A new era for the treatment of inflammatory autoimmune diseases by interleukin-6 blockade strategy.

artículo científico

Anti-interleukin-6 receptor antibody, tocilizumab, for the treatment of autoimmune diseases.

artículo científico publicado en 2011

Association of recombinant soluble IL-6-signal transducer, gp130, with a complex of IL 6 and soluble IL-6 receptor, and establishment of an ELISA for soluble gp130 ⬇️

artículo científico publicado el 1 de febrero de 1992

Clonal evolution and antigen recognition of anti-nuclear antibodies in acute systemic lupus erythematosus.

artículo científico publicado en 2017

Cloning and Functional Analysis of New Members of STAT Induced STAT Inhibitor (SSI) Family: SSI-2 and SSI-3 ⬇️

artículo científico publicado el 8 de agosto de 1997

Conflicting results from clinical observations and murine models: what is the role of plasminogen activators in tumor growth?

scientific article published on 01 June 2006

Differential processing of stromal-derived factor-1alpha and stromal-derived factor-1beta explains functional diversity.

artículo científico publicado en 2003

Dysbiosis Contributes to Arthritis Development via Activation of Autoreactive T Cells in the Intestine

artículo científico publicado en 2016

Effect of enzymatically modified isoquercitrin, a flavonoid, on symptoms of Japanese cedar pollinosis: a randomized double-blind placebo-controlled trial.

artículo científico publicado en 2009

Expansion of range of joint motion following treatment of systemic sclerosis with tocilizumab

artículo científico publicado en 2014

Functional inhibition of hematopoietic and neurotrophic cytokines by blocking the interleukin 6 signal transducer gp130 ⬇️

artículo científico publicado el 15 de noviembre de 1992

Fungal ITS1 Deep-Sequencing Strategies to Reconstruct the Composition of a 26-Species Community and Evaluation of the Gut Mycobiota of Healthy Japanese Individuals

artículo científico publicado en 2017

IL-6 in inflammation, immunity, and disease

artículo científico publicado en 2014

Identification of carboxypeptidase N as an enzyme responsible for C-terminal cleavage of stromal cell-derived factor-1alpha in the circulation

artículo científico publicado en 2005

Imatinib mesylate inhibited rat adjuvant arthritis and PDGF-dependent growth of synovial fibroblast via interference with the Akt signaling pathway.

artículo científico publicado en 2009

Immune reconstitution inflammatory syndrome in a patient with adult-onset Still's disease: graft-versus-host-like skin reaction with possible asymptomatic human herpes virus reactivation during steroid tapering.

artículo científico publicado en 2014

Immunotherapeutic implications of IL-6 blockade for cytokine storm.

artículo científico publicado en 2016

Improvement of HbA1c during treatment with humanised anti-interleukin 6 receptor antibody, tocilizumab

scientific article published on 26 October 2010

LRRK1 is critical in the regulation of B-cell responses and CARMA1-dependent NF-κB activation.

artículo científico publicado en 2016

Ligand-induced internalization selects use of common receptor neuropilin-1 by VEGF165 and semaphorin3A

artículo científico publicado en 2006

Minimal influence of tocilizumab on IFN-gamma synthesis by tuberculosis antigens

artículo científico publicado en 2009

Neuropilin-2: a new molecular target for antiangiogenic and antitumor strategies

artículo científico publicado en 2008

Oligo-guanosine nucleotide induces neuropilin-1 internalization in endothelial cells and inhibits angiogenesis

artículo científico publicado en 2010

Rapid improvement of AA amyloidosis with humanised anti-interleukin 6 receptor antibody treatment

artículo científico publicado en 2009

Receptor engagement by viral interleukin-6 encoded by Kaposi sarcoma-associated herpesvirus

artículo científico publicado en 2001

Recovery from prolonged thrombocytopenia in patients with TAFRO syndrome: case series and literature review

artículo científico publicado en 2020

Regulation of IL-6 in Immunity and Diseases.

artículo científico publicado en 2016

Regulation of intestinal homeostasis by the ulcerative colitis-associated gene RNF186.

artículo científico publicado en 2016

Retention of tocilizumab and anti-tumour necrosis factor drugs in the treatment of rheumatoid arthritis.

artículo científico publicado en 2013

Semaphorin 4D Contributes to Rheumatoid Arthritis by Inducing Inflammatory Cytokine Production: Pathogenic and Therapeutic Implications.

artículo científico publicado en 2015

Semaphorin 4D inhibits neutrophil activation and is involved in the pathogenesis of neutrophil-mediated autoimmune vasculitis.

artículo científico publicado en 2017

Sialylation converts arthritogenic IgG into inhibitors of collagen-induced arthritis.

artículo científico publicado en 2016

Structure and function of a new STAT-induced STAT inhibitor

scientific journal article

Successful treatment of acquired hemophilia A, complicated by chronic GVHD, with tocilizumab ⬇️

artículo científico publicado el 15 de enero de 2011

Successful treatment of reactive arthritis with a humanized anti-interleukin-6 receptor antibody, tocilizumab.

artículo científico publicado en 2009

Sulfated polysaccharides identified as inducers of neuropilin-1 internalization and functional inhibition of VEGF165 and semaphorin3A

artículo científico publicado en 2008

Sustained response to tocilizumab, anti-interleukin-6 receptor antibody, in two patients with refractory relapsing polychondritis

scientific article published on 23 December 2008

Targeting coagulation to the tumor microvasculature: perspectives and therapeutic implications from preclinical studies

artículo científico publicado en 2005

The Two-Faced Cytokine IL-6 in Host Defense and Diseases ⬇️

journal article from 'International Journal of Molecular Sciences' published in 2018

The role and therapeutic targeting of IL-6 in rheumatoid arthritis.

artículo científico

The skin of patients with systemic sclerosis softened during the treatment with anti-IL-6 receptor antibody tocilizumab.

artículo científico publicado en 2010

Therapeutic effect of tocilizumab on two patients with polymyositis

artículo científico publicado en 2011

Therapeutic targeting of the interleukin-6 receptor.

artículo científico

Tumor cell populations differ in angiogenic activity: a model system for spontaneous angiogenic switch can tell us why

scientific article published on 01 March 2006

Vav is associated with signal transducing molecules gp130, Grb2 and Erk2, and is tyrosine phosphorylated in response to interleukin-6

artículo científico publicado en 1997

Viral interleukin 6 stimulates human peripheral blood B cells that are unresponsive to human interleukin 6.

artículo científico publicado en 2001

What kind of durometer is best suited for the assessment of skin disease in systemic sclerosis? Comment on the article by Kissin et al

scientific article published on 01 April 2008

Lista de obras de Masashi Narazaki

A case of Behçet's disease treated with a humanized anti-interleukin-6 receptor antibody, tocilizumab.

A new era for the treatment of inflammatory autoimmune diseases by interleukin-6 blockade strategy.

Anti-interleukin-6 receptor antibody, tocilizumab, for the treatment of autoimmune diseases.

Association of recombinant soluble IL-6-signal transducer, gp130, with a complex of IL 6 and soluble IL-6 receptor, and establishment of an ELISA for soluble gp130 ⬇️

Clonal evolution and antigen recognition of anti-nuclear antibodies in acute systemic lupus erythematosus.

Cloning and Functional Analysis of New Members of STAT Induced STAT Inhibitor (SSI) Family: SSI-2 and SSI-3 ⬇️

Conflicting results from clinical observations and murine models: what is the role of plasminogen activators in tumor growth?

Differential processing of stromal-derived factor-1alpha and stromal-derived factor-1beta explains functional diversity.

Dysbiosis Contributes to Arthritis Development via Activation of Autoreactive T Cells in the Intestine

Effect of enzymatically modified isoquercitrin, a flavonoid, on symptoms of Japanese cedar pollinosis: a randomized double-blind placebo-controlled trial.

Expansion of range of joint motion following treatment of systemic sclerosis with tocilizumab

Functional inhibition of hematopoietic and neurotrophic cytokines by blocking the interleukin 6 signal transducer gp130 ⬇️

Fungal ITS1 Deep-Sequencing Strategies to Reconstruct the Composition of a 26-Species Community and Evaluation of the Gut Mycobiota of Healthy Japanese Individuals

IL-6 in inflammation, immunity, and disease

Identification of carboxypeptidase N as an enzyme responsible for C-terminal cleavage of stromal cell-derived factor-1alpha in the circulation

Imatinib mesylate inhibited rat adjuvant arthritis and PDGF-dependent growth of synovial fibroblast via interference with the Akt signaling pathway.

Immune reconstitution inflammatory syndrome in a patient with adult-onset Still's disease: graft-versus-host-like skin reaction with possible asymptomatic human herpes virus reactivation during steroid tapering.

Immunotherapeutic implications of IL-6 blockade for cytokine storm.

Improvement of HbA1c during treatment with humanised anti-interleukin 6 receptor antibody, tocilizumab

LRRK1 is critical in the regulation of B-cell responses and CARMA1-dependent NF-κB activation.

Ligand-induced internalization selects use of common receptor neuropilin-1 by VEGF165 and semaphorin3A

Minimal influence of tocilizumab on IFN-gamma synthesis by tuberculosis antigens

Neuropilin-2: a new molecular target for antiangiogenic and antitumor strategies

Oligo-guanosine nucleotide induces neuropilin-1 internalization in endothelial cells and inhibits angiogenesis

Rapid improvement of AA amyloidosis with humanised anti-interleukin 6 receptor antibody treatment

Receptor engagement by viral interleukin-6 encoded by Kaposi sarcoma-associated herpesvirus

Recovery from prolonged thrombocytopenia in patients with TAFRO syndrome: case series and literature review

Regulation of IL-6 in Immunity and Diseases.

Regulation of intestinal homeostasis by the ulcerative colitis-associated gene RNF186.

Retention of tocilizumab and anti-tumour necrosis factor drugs in the treatment of rheumatoid arthritis.

Semaphorin 4D Contributes to Rheumatoid Arthritis by Inducing Inflammatory Cytokine Production: Pathogenic and Therapeutic Implications.

Semaphorin 4D inhibits neutrophil activation and is involved in the pathogenesis of neutrophil-mediated autoimmune vasculitis.

Sialylation converts arthritogenic IgG into inhibitors of collagen-induced arthritis.

Structure and function of a new STAT-induced STAT inhibitor

Successful treatment of acquired hemophilia A, complicated by chronic GVHD, with tocilizumab ⬇️

Successful treatment of reactive arthritis with a humanized anti-interleukin-6 receptor antibody, tocilizumab.

Sulfated polysaccharides identified as inducers of neuropilin-1 internalization and functional inhibition of VEGF165 and semaphorin3A

Sustained response to tocilizumab, anti-interleukin-6 receptor antibody, in two patients with refractory relapsing polychondritis

Targeting coagulation to the tumor microvasculature: perspectives and therapeutic implications from preclinical studies

The Two-Faced Cytokine IL-6 in Host Defense and Diseases ⬇️

The role and therapeutic targeting of IL-6 in rheumatoid arthritis.

The skin of patients with systemic sclerosis softened during the treatment with anti-IL-6 receptor antibody tocilizumab.

Therapeutic effect of tocilizumab on two patients with polymyositis

Therapeutic targeting of the interleukin-6 receptor.

Tumor cell populations differ in angiogenic activity: a model system for spontaneous angiogenic switch can tell us why

Vav is associated with signal transducing molecules gp130, Grb2 and Erk2, and is tyrosine phosphorylated in response to interleukin-6

Viral interleukin 6 stimulates human peripheral blood B cells that are unresponsive to human interleukin 6.

What kind of durometer is best suited for the assessment of skin disease in systemic sclerosis? Comment on the article by Kissin et al